To The Moon

$Palantir(PLTR)$ Technologies reported another quarter of record revenue on Monday, propelled by a surge in new customers flocking to buy artificial-intelligence technology from one of the hottest...

The White House said it had learned there likely will not be a release of inflation data next month due to the U.S. government shutdown, which could leave a gap in a data series stretching back more than a century.

Administration wants domestic manufacturing to match imports and would impose tariffs on those companies that don’t step up production.

The Singapore government said on Thursday it has given $Meta Platforms(META)$ until the end of this month to introduce measures including facial recognition to help curb impersonation scams on...

JPMorgan has raised its price target on Apple to $280.00 from $255.00 while maintaining an Overweight rating, citing favorable early demand for the iPhone 17 series.

Rare earth stocks rose on Tuesday. USA Rare Earth up 12%; American Resources up 7%; The Metals up 3%; MP Materials up 1%.The US is in talks to set up a $5 billion fund to invest in mining, in what...

Biotech stocks plunged on Wednesday. Ascletis Pharma down 14%; Clover Bio, Transcenta down over 10%; Beigene, HBM Holdings down over 8%; Jacobio down over 7%.President Donald Trump told European...

0734 GMT - Chagee may continue facing same-store sales pressure in 2H, as it attempts to avoid price wars to preserve its premium position, say Citi analysts in a note. While the company maintaining its premium branding should be favorable over the long term, the analysts trim their nearer-term forecasts. They lower adjusted core net profit projections by 11% and 8% for 2025 and 2026, respectively. They also estimate that 2025 same-store sales will fall 17% instead of the previously-assumed 13%. Citi opens a 30-day short-term negative view on Chagee, and lowers the target price on its ADR to US$29.50 from US$35.40 with a buy/high risk rating. The ADRs last closed at US$19.11.